These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3989694)

  • 1. Variation in hepatic extraction ratio with unbound drug fraction: discrimination between models of hepatic drug elimination.
    Byrne AJ; Morgan DJ; Harrison PM; McLean AJ
    J Pharm Sci; 1985 Feb; 74(2):205-7. PubMed ID: 3989694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
    Wang HJ; Benet LZ
    Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.
    Smallwood RH; Morgan DJ; Mihaly GW; Jones DB; Smallwood RA
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):377-96. PubMed ID: 3193365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.
    Rowland M; Leitch D; Fleming G; Smith B
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):129-47. PubMed ID: 6491897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    Ching MS; Morgan DJ; Smallwood RA
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1048-54. PubMed ID: 2778709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic models of hepatic drug clearance: influence of altered protein binding on the elimination of diclofenac in the isolated perfused rat liver.
    Hussein Z; Evans AM; Rowland M
    J Pharm Sci; 1993 Sep; 82(9):880-5. PubMed ID: 8229684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance.
    Schulz Pauly JA; Wang J; Phipps CJ; Kalvass JC
    Drug Metab Dispos; 2023 Aug; 51(8):1046-1052. PubMed ID: 37188529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic elimination of drugs with concentration-dependent serum protein binding.
    Huang JD; Oie S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.
    Jansen JA
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):15-26. PubMed ID: 7229915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.
    Díaz-García JM; Evans AM; Rowland M
    J Pharmacokinet Biopharm; 1992 Apr; 20(2):171-93. PubMed ID: 1629795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of route of input on the hepatic disposition of diazepam.
    Sahin S; Rowland M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):836-43. PubMed ID: 11046126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
    Ahmad AB; Bennett PN; Rowland M
    J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.
    Smallwood RH; Mihaly GW; Smallwood RA; Morgan DJ
    J Pharmacokinet Biopharm; 1988 Oct; 16(5):529-42. PubMed ID: 3199317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model.
    Hsu SH; Cheng AC; Chang TY; Pao LH; Hsiong CH; Wang HJ
    Biomed Pharmacother; 2021 Sep; 141():111855. PubMed ID: 34229248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes.
    Kwon Y; Morris ME
    Pharm Res; 1997 Jun; 14(6):780-5. PubMed ID: 9210197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver.
    Mitchell SJ; Huizer-Pajkos A; Cogger VC; McLachlan AJ; Le Couteur DG; Jones B; de Cabo R; Hilmer SN
    Pharmacology; 2012; 90(5-6):233-41. PubMed ID: 23007459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.